ATRX and neoplasm: Additionally, loss of ATRX induces an immunosuppressive microenvironment in gliomas by promoting the secretion of immunosuppressive cytokines and upregulating the expression of immune checkpoint molecules, suppressing anti‐tumor immunity.72